Stocksigma LogoStocksigma Logo

Hemant Surgical Reports Strong H1 FY27 Results with Multi-Fold Profit Growth

Hemant Surgical Industries reported consolidated revenue from operations of ₹27,631.06 lakhs for the half year ended 30th Sep'26, up 327.6% YoY from

Hemant Surgical Reports Strong H1 FY27 Results with Multi-Fold Profit Growth

Hemant Surgical Industries Ltd · Financial Result · 14 Nov 2026, 9:42 pm

Hemant Surgical Reports Strong H1 FY27 Results with Multi-Fold Profit Growth Hemant Surgical Industries reported consolidated revenue from operations of ₹27,631.06 lakhs for the half year ended 30th Sep'26, up 327.6% YoY from ₹6,462.01 lakhs in H1 FY26. Consolidated net profit attributable to owners surged 245% YoY to ₹1,883.82 lakhs against ₹545.98 lakhs. Basic EPS rose to ₹13.30 from ₹5.15 YoY. Standalone revenue and PAT stood at ₹27,592.01 lakhs and ₹1,911.75 lakhs, respectively. The company also integrated Lifesenz Cancer Research Labs as a 66.66% subsidiary effective 1st Jun'26.

Original exchange filing (PDF)

More announcements from Hemant Surgical Industries Ltd

All Hemant Surgical Industries Ltd announcements